BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
34 hedge funds and large institutions have $560K invested in BRAINSTORM CELL THERAPUTC in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 17 closing their positions.
Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
11
Closed
17
Calls
$23K
Puts
–
Net Calls
+$23K
Net Calls Change
+$10K
Top Buyers
1 |
HF
1
HRT Financial
New York
|
$45K |
2 |
TSS
2
Two Sigma Securities
New York
|
$25.7K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$119K |
4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$13.7K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$7.88K |